Literature DB >> 19874332

Neurotropin inhibits both capsaicin-induced substance P release and nerve growth factor-induced neurite outgrowth in cultured rat dorsal root ganglion neurones.

K Taneda1, M Tominaga, S Tengara, H Ogawa, K Takamori.   

Abstract

BACKGROUND: Neurotropin (NTP), a biological extract from rabbit skin inoculated with vaccinia virus, is an effective analgesic and anti-allergic agent, and has antipruritic effects in various dermatoses including eczema, dermatitis and urticaria. In patients receiving haemodialysis who have pruritus, NTP appears to exert its antipruritic effect by lowering the plasma levels of substance P (SP), but its underlying mechanisms are not fully understood. AIM: To investigate the antipruritic mechanisms of NTP.
METHODS: The effects of NTP on capsaicin-induced SP release from neonatal rat dorsal root ganglion (DRG) neurones were assessed by measuring SP concentrations in culture media by a competitive ELISA. The effects of NTP on nerve growth factor (NGF)-induced neurite outgrowth were assessed by measuring the length of the longest process of cultured DRG neurones. The neuronal cytotoxicity of NTP was determined using a methylthiazole tetrazolium cytotoxicity assay.
RESULTS: NTP dose-dependently inhibited capsaicin-induced release of SP from cultured DRG neurones, whereas NTP alone had no effect on SP release. Moreover, NTP dose-dependently inhibited NGF-induced neurite outgrowth in cultured DRG neurones. NTP had no observable cytotoxicity.
CONCLUSIONS: These results suggest that NTP exerts its antipruritic effects by inhibiting both SP release and neurite outgrowth of cutaneous sensory nerves.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874332     DOI: 10.1111/j.1365-2230.2009.03636.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V.

Authors:  Giovanna Testa; Marco Mainardi; Chiara Morelli; Francesco Olimpico; Laura Pancrazi; Carla Petrella; Cinzia Severini; Rita Florio; Francesca Malerba; Antonia Stefanov; Enrica Strettoi; Rossella Brandi; Ivan Arisi; Paul Heppenstall; Mario Costa; Simona Capsoni; Antonino Cattaneo
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

2.  Success with neurotropin in treating pediatric lower extremity pain induced by spinal cord injury after epidural anesthesia.

Authors:  Mengye Zhu; Fuqing Zhou; Lingchao Li; Qin Yin; Mizhen Qiu; Yong Zhang
Journal:  J Pain Res       Date:  2017-06-06       Impact factor: 3.133

3.  hNGF Peptides Elicit the NGF-TrkA Signalling Pathway in Cholinergic Neurons and Retain Full Neurotrophic Activity in the DRG Assay.

Authors:  Viviana Triaca; Elena Fico; Valentina Sposato; Silvia Caioli; Maria Teresa Ciotti; Cristina Zona; Delio Mercanti; Diego La Mendola; Cristina Satriano; Enrico Rizzarelli; Paola Tirassa; Pietro Calissano
Journal:  Biomolecules       Date:  2020-02-01

4.  Neurotropin exerts neuroprotective effects after spinal cord injury by inhibiting apoptosis and modulating cytokines.

Authors:  Xue Yao; Chao Sun; Baoyou Fan; Chenxi Zhao; Yan Zhang; Huiquan Duan; Yilin Pang; Wenyuan Shen; Bo Li; Xu Wang; Chang Liu; Hengxing Zhou; Xiaohong Kong; Shiqing Feng
Journal:  J Orthop Translat       Date:  2020-03-23       Impact factor: 5.191

5.  The relationship between the severity of clinical symptoms of chronic urticaria and serum D-dimer levels.

Authors:  Anna Sadowska-Przytocka; Magdalena Czarnecka-Operacz; Katarzyna Łącka; Dorota Jenerowicz; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2020-04-23       Impact factor: 1.837

Review 6.  Treatment Options for Troublesome Itch.

Authors:  Sumika Toyama; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-19

Review 7.  Mechanisms and Management of Itch in Dry Skin.

Authors:  Catharina Sagita Moniaga; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Acta Derm Venereol       Date:  2020-01-15       Impact factor: 3.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.